Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:CCEL NASDAQ:DCGO NASDAQ:EUDA NASDAQ:XGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCCELCryo-Cell International$4.67-1.2%$4.83$4.09▼$9.43$37.60M0.6713,117 shs4,639 shsDCGODocGo$1.55+0.6%$1.53$1.23▼$5.68$151.12M0.97827,756 shs185,107 shsEUDAEUDA Health$1.69-9.1%$2.94$1.65▼$6.30$62.95M-0.196,137 shs81,392 shsXGNExagen$9.59-0.3%$8.24$2.38▼$10.34$211.31M1.6230,012 shs60,590 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCCELCryo-Cell International+0.43%+7.27%-4.84%-5.79%-10.27%DCGODocGo-1.28%-6.67%+15.79%+6.94%-59.26%EUDAEUDA Health-9.71%-17.33%-41.14%-41.51%-62.27%XGNExagen-2.54%-2.93%+11.36%+30.39%+222.48%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCCELCryo-Cell International3.6011 of 5 stars3.53.01.70.03.73.30.0DCGODocGo2.5611 of 5 stars3.34.00.00.02.30.80.6EUDAEUDA Health0.5087 of 5 stars0.03.00.00.02.40.00.6XGNExagen4.3075 of 5 stars2.55.00.04.53.12.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCCELCryo-Cell International 3.00Buy$8.5082.21% UpsideDCGODocGo 2.50Moderate Buy$3.59131.61% UpsideEUDAEUDA Health 4.00Strong BuyN/AN/AXGNExagen 3.00Buy$11.2517.37% UpsideCurrent Analyst Ratings BreakdownLatest CCEL, DCGO, XGN, and EUDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/21/2025DCGODocGoCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$1.45 ➝ $1.607/30/2025XGNExagenCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$10.007/30/2025XGNExagenCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.00 ➝ $11.007/30/2025XGNExagenKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeSector Weight ➝ Overweight$12.007/23/2025XGNExagenCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.00(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCCELCryo-Cell International$31.99M1.18$0.18 per share26.22($1.64) per share-2.84DCGODocGo$616.55M0.25$0.42 per share3.69$2.94 per share0.53EUDAEUDA Health$4.01M15.66N/AN/A($0.07) per share-24.14XGNExagen$55.64M3.79N/AN/A$0.96 per share9.98Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCCELCryo-Cell International$400K-$1.06N/A∞N/A-0.53%-1.07%-0.27%N/ADCGODocGo$19.99M-$0.19N/A19.38N/A-4.20%-3.26%-2.24%11/6/2025 (Estimated)EUDAEUDA Health-$15.36MN/A0.00N/AN/AN/AN/AN/AN/AXGNExagen-$15.11M-$0.89N/AN/AN/A-28.85%-130.38%-34.69%11/11/2025 (Estimated)Latest CCEL, DCGO, XGN, and EUDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025DCGODocGo-$0.06-$0.11-$0.05-$0.11$77.58 million$80.42 million7/29/2025Q2 2025XGNExagen-$0.18-$0.18N/A-$0.21$16.25 million$17.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCCELCryo-Cell International$0.6012.86%N/AN/A N/ADCGODocGoN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/AXGNExagenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCCELCryo-Cell InternationalN/A0.600.57DCGODocGoN/A2.362.36EUDAEUDA HealthN/A0.180.15XGNExagen1.064.954.95Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCCELCryo-Cell International10.44%DCGODocGo56.44%EUDAEUDA Health4.35%XGNExagen75.25%Insider OwnershipCompanyInsider OwnershipCCELCryo-Cell International36.86%DCGODocGo3.80%EUDAEUDA HealthN/AXGNExagen12.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCCELCryo-Cell International908.06 million5.09 millionNot OptionableDCGODocGo4,40797.81 million94.09 millionOptionableEUDAEUDA Health237.16 millionN/ANot OptionableXGNExagen22022.00 million19.23 millionOptionableCCEL, DCGO, XGN, and EUDA HeadlinesRecent News About These CompaniesStonepine Capital Management LLC Sells 155,302 Shares of Exagen Inc. $XGNAugust 26, 2025 | marketbeat.comShort Interest in Exagen Inc. (NASDAQ:XGN) Expands By 52.8%August 20, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Buy" by BrokeragesAugust 18, 2025 | marketbeat.comExagen Inc. to Participate in Third Quarter Investor ConferencesAugust 6, 2025 | gurufocus.comExagen Inc. to Participate in Third Quarter Investor ConferencesAugust 6, 2025 | globenewswire.comExagen Inc. (NASDAQ:XGN) Short Interest Up 144.8% in JulyAugust 4, 2025 | marketbeat.comBTIG Sticks to Their Buy Rating for Exagen (XGN)August 2, 2025 | theglobeandmail.comExagen (XGN) Receives a Buy from Craig-HallumAugust 1, 2025 | theglobeandmail.comExagen Inc. Reports Record Revenue Amidst Growth ChallengesAugust 1, 2025 | theglobeandmail.comCanaccord Genuity Sticks to Its Buy Rating for Exagen (XGN)July 31, 2025 | theglobeandmail.comXGN | Exagen Inc. Annual Cash Flow Statement | MarketWatchJuly 31, 2025 | marketwatch.comKeybanc Upgrades Exagen (XGN)July 31, 2025 | msn.comExagen upgraded to Overweight from Sector Weight at KeyBancJuly 30, 2025 | msn.comExagen Q2 Revenue Jumps 14 PercentJuly 29, 2025 | aol.comAExagen Inc. (XGN) Q2 2025 Earnings Call TranscriptJuly 29, 2025 | seekingalpha.comExagen Inc. (XGN) Reports Q2 Loss, Beats Revenue EstimatesJuly 29, 2025 | zacks.comExagen Inc. Reports Strong Q2 2025 ResultsJuly 29, 2025 | globenewswire.comCraig-Hallum Initiates Coverage of Exagen (XGN) with Buy RecommendationJuly 25, 2025 | msn.comExagen Inc. (XGN): A Bull Case TheoryJuly 24, 2025 | msn.comExagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock?July 24, 2025 | zacks.comTD Cowen Remains a Buy on Exagen (XGN)July 23, 2025 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAn Atomic Sized Surge Is Brewing for NuScale Power Stock PriceBy Thomas Hughes | August 11, 20253 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 2025Lowe’s Builds Value for Investors: Still a Good Buy in 2025By Thomas Hughes | August 20, 2025Disney’s Iger-Led Turnaround Gains TractionBy Thomas Hughes | August 6, 2025MongoDB Roars Back to Life: It’s Not Too Late to Buy MoreBy Thomas Hughes | August 27, 2025CCEL, DCGO, XGN, and EUDA Company DescriptionsCryo-Cell International NYSEAMERICAN:CCEL$4.66 -0.06 (-1.17%) As of 03:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.DocGo NASDAQ:DCGO$1.55 +0.01 (+0.65%) As of 03:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.EUDA Health NASDAQ:EUDA$1.69 -0.17 (-9.14%) As of 03:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.Exagen NASDAQ:XGN$9.59 -0.03 (-0.26%) As of 03:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Shares Can Hit a Fresh High Before Year-End Taiwan Semiconductor Falls on China News—Buy The Dip? CrowdStrike Tests $412 Support as Options Traders Turn Bullish What to Expect From the Q3 Reporting Season IREN Is Up 186% YTD on AI Pivot—And It’s Just Getting Started Loop Industries Insiders Buy Stock, Signal Confidence in Outlook Joby Aviation's Pullback: A Gift for Investors Who See the Future Opera Limited Stock Set to End 2025 on a High Note Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
